By inhibiting P-gp, the d-a-tocopheryl polythene glycol 1000 succinate (TPGS) may increase membrane permeability to a drug, improve drug absorption and decrease P-gp-mediated MDR in cancer cells (Constantinou et al., 2008; Ma et al., 2010). This evidence concerns the gene PGP and cancer.